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Abstract 
Coccidiosis is endemic in the commercial broiler industry capable of inflicting devastating economic losses to poultry 
operations. Vaccines are relatively effective in controlling the disease; their efficacy could potentially be improved with 
concurrent use of probiotics as evaluated in this study using an Eimeria challenge. Day of hatch 400 Cobb‑500 male 
broilers were assigned to one of four treatment groups including control (CON), vaccine‑only gel application (VNC), 
probiotic‑only gel application (NPC), and vaccine‑plus‑probiotic gel application (VPC). Birds were placed in floor pens 
(6 replicate pens/treatment, 16–17 birds/pen). NPC and VPC birds received the probiotics in the water on days 2–4, 8, 
14–20, 22, 29, and 34–36. On day 15, birds were mildly challenged with 0.5 mL of a mixed oral inoculum of Eimeria sp. 
prepared with the coccidiosis vaccine at 10× the vaccination dose. Performance measurements were recorded on 
first day and weekly afterwards, and lesion scores were evaluated 6 days post‑challenge. Overall, the probiotics and 
coccidiosis vaccine resulted in an enhanced protective effect against the challenge, with VPC birds exhibiting lower 
lesion scores in the duodenum than VNC or NPC birds. Birds in the VPC treatment also demonstrated higher weight 
gains during days 1–15, days 7–15, and days 21–28 when compared to the VNC birds. These results suggest that the 
combination of probiotics and coccidiosis vaccines could enhance performance and provide an additional protective 
effect against a mixed Eimeria challenge.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The practice of supplying food animals with sub-ther-
apeutic doses of antibiotics to protect against coccidi-
osis infections and improve general intestinal health 
has recently been under scrutiny. The relatively recent 
ban of sub-therapeutic doses of certain antibiotics as 
feed additives in the European Union has led to a gen-
eral decline in animal health with increased incidences of 
enteric conditions [1] known as dysbiosis. This outcome, 
as well as the threat of a domestic ban, has led research-
ers to explore the next promising alternatives including 
probiotics and potential combinations with live oocyst 
vaccines.
Although the primary function of the gastrointestinal 
tract is to digest and absorb nutrients, a well-balanced 
gut microbiota is crucial for optimal animal health and 
performance. The gastrointestinal tract also serves as 
a vital barrier preventing the entry of potentially harm-
ful pathogens and other environmental antigens [2]. As 
the gut microbiota begins to establish within hours after 
the chick hatches, the earlier the introduction of non-
pathogenic microorganisms, the more effective their 
establishment in the digestive tract [3, 4]. Also known as 
direct-fed microbials, probiotics are classified as live non-
pathogenic microorganisms that are capable of maintain-
ing a normal gut microbial population [5, 6]. Probiotics 
can help maintain a healthy balance of microorganisms 
through multiple modes of action including competitive 
exclusion, pathogen antagonism, and stimulation of the 
immune system [6, 7]. Probiotics may provide a poten-
tial alternative to the prophylactic use of drugs in food 
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animals due to their studied abilities to reduce severity 
of enteric diseases and enhance performance in poultry 
[5, 8–10]. Probiotics can be composed of one or many 
strains of microbial species, with the more common ones 
belonging to the genera Lactobacillus, Bifidobacterium, 
Enterococcus, Bacillus, and Pediococcus [11].
Coccidiosis is endemic in the commercial broiler industry 
and inflicts devastating economic losses to poultry opera-
tions estimated to cost the industry about US $3 billion 
annually worldwide [12]. Coccidiosis is caused by develop-
ment and reproduction of multiple species of the Eimeria 
protozoa, leading to impaired growth and feed utilization 
and predisposing birds to secondary infections. Anticoccid-
ial compounds have been used to control coccidiosis, but 
Eimeria species have developed resistance to both chemical 
and ionophore drugs over time [13]. As such, the use of live 
vaccines to control coccidiosis has greatly increased. Vac-
cines provide an alternative for disease protection, and they 
ultimately help in reducing Eimeria resistance as they sys-
tematically replace resistant field strains and induce specific 
protective immunity by exposing the chicken’s immune sys-
tem to Eimeria antigens [13–15]. Immunity is subsequently 
boosted and maintained by multiple re-infections caused 
by oocysts present in the litter due to shedding and inges-
tion [14]. Early and uniform administration of live oocysts 
of the vaccine results in a low level infection, necessary for 
immunity development. However, it can cause an early 
reduction in growth and may increase the chick’s suscep-
tibility to secondary infections, such as necrotic enteritis 
[13, 15, 16]. The potential consequences of coccidiosis vac-
cine administration at a young age could be overcome by 
proper and uniform delivery of the vaccine, as well as the 
chick having a healthy intestinal tract colonized by a nor-
mal pathogen-free microbiota [13, 15]. Probiotics have the 
potential to enhance host defenses and affect the digestive 
microbiota positively, while protecting against colonization 
by harmful bacteria and maintaining intestinal integrity 
[13, 15, 17–19]. Based on these findings, probiotics may be 
able to attenuate the negative consequences of early vac-
cine administration. This study aimed to evaluate the com-
bined protective effects of a probiotic product (PoultryStar, 
BIOMIN GmbH, Austria) containing Enterococcus, Bifi-
dobacterium, Pediococcus and Lactobacillus species, and 
a coccidiosis vaccine (Immucox I, CEVA Santé Animale, 
Canada) containing Eimeria acervulina, E. maxima, E. nec-




The study performed was a 42-day grow-out with 400 
Cobb-500 male broilers housed on randomized floor pens 
(furnished with  ~10  cm of clean wood shavings, which 
remained throughout the study period), with 6 replicate 
pens per treatment and 16 or 17 birds per pen. On day of 
hatch (DOH), 100 birds were treated for each of the fol-
lowing four treatments at the hatchery: 1) control (CON), 
2) vaccinated-only (VNC), 3) water-applied probiotic 
only (NPC), and 4) vaccinated and water-applied probi-
otic (VPC). VNC and VPC birds received Immucox I vac-
cine through gel droplet administration at the hatchery. 
Birds in NPC and VPC received probiotics via gel droplet 
application at the hatchery using a Desvac Gel Dispenser, 
as well as in the water intermittently through the course 
of the trial. The gel product was prepared using cold tap 
water and the dried gel component provided with the 
vaccine. Once water was added, the live oocyst vaccine, 
probiotic product, or both were added based on treat-
ment. Then, the components were thoroughly mixed with 
a hand held mixer on low speed until the mixture was 
consistent and all probiotic product was dissolved. Once 
prepared, the mixture was applied using a commercial 
gel droplet applicator. The probiotics were administered 
in the water at 20 mg/bird per day on the first three days 
after placement, once a week, the week of Eimeria species 
challenge starting one day prior to inoculation, and one 
day before, the day of, and one day after a feed change. In 
summary, probiotics were administered a total of 17 time 
points, including days 2–4, 8, 14–20, 22, 29, and 34–36 
(shown in Table 1). All birds received a basal diet ad libi-
tum (Table  2). All animal protocols were approved and 
conducted under the guidelines of the Virginia Tech Insti-
tutional Animal Care and Use Committee. 
Eimeria challenge
On day 15 of age, birds were challenged via oral gavage 
with 0.5  mL of the Immucox I coccidiosis vaccine, pro-
viding 10×  the vaccine dose given at hatch, initiating a 
mixed Eimeria challenge. On day 21 (6 days post infec-
tion), 18 birds per treatment were randomly selected and 
euthanized for scoring of lesions from intestinal Eimeria 
infection. Lesions in the duodenum, jejunum, ileum and 
ceca were scored by the method of Johnson and Reid 
[20] by personnel blinded to treatments based on scores 
ranging from 0 (no gross lesion) to 4 (most severe lesion). 
Excreta samples were collected from each pen on days 
6–8 and 14 after challenge. For each pen, fresh excreta 
samples were collected from either side of the feeder, 
either side of the water supply, and from the center of the 
pen. Samples were kept in separate airtight plastic bags. 
Starting excreta weights were recorded for each sam-
ple for later calculations of oocysts per gram of excreta 
as previously described [17]. After homogenization, 
samples were stored at 4  °C until oocysts were counted 
microscopically after dilution using a McMaster counting 
chamber and expressed as oocysts per gram of excreta. 
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Weekly litter samples were collected from each pen to 
assess moisture content. Five samples were taken from 
each pen once a week and stored in airtight plastic bags. 
The samples were transferred to paper bags and placed 
in a drying oven at 55 °C for 24 h, with both starting and 
final weights recorded. From days 15–24, excreta in each 
pen were evaluated and scored for bloody diarrhea as 
described by Youn and Noh [21].
Performance
Pen and feed weights were taken on DOH, days 7, 15, 21, 
28, 35 and 42. From these data, body weight (BW), body 
weight gain (BWG), feed intake (FI), and feed conversion 
ratio (FCR) were determined on a pen basis, and then 
averaged by treatment. Mortality was checked twice daily 
and feed consumption was corrected accordingly. One 
VNC pen was excluded from all calculations due to high 
mortality in the first week of the study due to undeter-
mined but suspected metabolic conditions.
Statistical analysis
Data were analyzed using the Fit Model platform in JMP 
Pro 10.0 (SAS Institute Inc., Cary, NC, USA). For perfor-
mance measurements, oocyst shedding, and litter mois-
ture analysis, the model included treatment with pen 
representing the experimental unit. Lesion score analysis 
was performed with treatment in the model with bird serv-
ing as the experimental unit. Differences among experi-
mental treatments were tested using Tukey HSD following 
ANOVA. Values were considered statistically different at 
P ≤ 0.05. Results are reported as Least Square Means (LS 




On day 21, a significant effect of treatment (P < 0.0001) 
was noted in lesion scores in the duodenum, the site of E. 
acervulina infection, as presented in Figure 1. The CON 
Table 1 Administration of probiotics (PoultryStar®) in water to appropriate treatments
* Indicates probiotics were included in the drinking water at 20 mg/bird in each pen.
CON: control, VNC: vaccine administration only, NPC: probiotic administration only, VPC: both vaccine and probiotic administration.




 NPC * * * * * * * * * * * * * * * *
 VPC * * * * * * * * * * * * * * * *
Table 2 Composition of broiler diets during 3 growing 
phases







 Corn 60.55 65.63 69.90
 Soybean meal 22.42 16.43 10.76








 l‑Lysine 0.63 0.60 0.80
 Limestone 0.58 0.54 0.70
 DL‑Methionine 0.18 0.30 0.80
 Salt 0.27 0.17 0.16
 l‑Threonine 0.10 0.10 0.10








 Optiphos 0.01 0.01 0.01
Total 100.00 100.00 100.00
Calculated nutrient level
 ME, kcal/kg 3036.00 3102.00 3157.00
 CP, % 21.00 19.00 17.00
 Ca, % 0.90 0.80 0.76
 Available P, % 0.45 0.40 0.35
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birds had significantly higher lesion scores than VNC 
and VPC birds (P < 0.0001). No lesions were observed in 
the duodenum of VPC birds, resulting in VPC being sig-
nificantly different from all other treatments. The jeju-
num is one segment prone to damage from E. maxima 
and E. necatrix; the CON birds exhibited significantly 
higher lesions in the jejunum than all other treatments 
(P  <  0.0001). No lesions were observed in the ileum of 
VNC or NPC birds on day 21. The average lesion scores 
in the ileum for CON and VPC birds were low, resulting 
in no significant differences seen among treatments. In 
addition, no lesions were observed in the ceca, the site of 
E. tenella infection, in any treatment (data not shown as 
all scores were effectively zero).
Litter moisture
Figure  2A represents the significant effect of treatment 
(P = 0.0119) on litter moisture noted on day 7. The litter 
present in the VNC pens had significantly less moisture 
when compared to CON and VPC pens. Litter moisture 
also demonstrated a significant effect of treatment on day 
14 (Figure 2B) where VNC pens had lower (P < 0.0001) 
litter moisture when compared to all other treatments. 
In addition, NPC pens had higher percent moisture of 
the litter when compared to the CON pens (P < 0.0001). 
At the end of the trial, a significant effect of treatment 
(P = 0.0245) was noted on percent moisture of the litter. 
Shown in Figure  2C, NPC pens had significantly higher 
percent moisture than VNC pens only.
Bloody diarrhea scores
No significant differences among treatments were noted 
regarding the presence of bloody diarrhea from days 
15–24 (data not shown).
Performance
Results for performance parameters are summarized in 
Table 3.
Body weight (BW)
A significant effect of treatment (P = 0.00078) was seen 
on day 15, with NPC and VPC birds demonstrating sig-
nificantly higher average BW than VNC birds, while 
CON birds were comparable to all other treatments. 
A significant effect of treatment was also seen on day 








































Figure 1 Effect of administration of probiotics (PoultryStar) 
and coccidiosis vaccine (Immucox I) on day 21 lesion scores in 
the duodenum, jejunum, and ileum of Cobb-500 male broiler 
challenged with Eimeria species on day 15. Data are presented as 
Least Square Mean ± SEM; bars lacking a common letter differ signifi‑
cantly. CON: control; VNC: vaccine administration only; NPC: probiotic 

































































Figure 2 Effect of administration of probiotics (PoultryStar) 
and coccidiosis vaccine (Immucox I) on litter moisture on 
days 7 (A), 14 (B), and 42 (C) in pens of Cobb-500 male broiler 
chickens. Data are presented as Least Square Mean ± SEM; bars lack‑
ing a common letter differ significantly. CON: control; VNC: vaccine 
administration only; NPC: probiotic administration only, VPC: both 
vaccine and probiotic administration.
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Table 3 Effect of administration of probiotics (PoultryStar) and coccidiosis vaccine (Immucox I) on performance
a CON: control, VNC: vaccine administration only, NPC: probiotic administration only, VPC: vaccine and probiotic administration, DOH: day of hatch.
A–B Means within rows that do not have a common superscript differ significantly (P ≤ 0.05).
Variable Treatmenta SEM P value
CON VNC NPC VPC
DOH‑day 7
 DOH BW, g 37.41A 37.37A 38.23A 37.39A 0.25 0.6090
 Day 7 BW, g 150.85A 142.37A 154.17A 150.50A 3.31 0.1039
 BWG, g 113.44A 105.00A 116.33A 113.1A 3.28 0.1202
 FI, g/bird/day 30.01A 28.14A 37.62A 37.61A 3.31 0.1111
FCR 1.86A 1.85A 2.27A 2.33A 0.21 0.2525
 Days 7–15
 Day 15 BW, g 362.93AB 341.23B 379.42A 379.22A 7.88 0.0078
 BWG, g 212.08AB 198.87B 225.25AB 228.72A 7.08 0.0289
 FI, g/bird/day 46.82B 59.89A 48.38AB 49.03AB 3.31 0.0425
 FCR 1.55A 2.14B 1.50A 1.51A 0.13 0.0074
Days 15–21
 Day 21 BW, g 621.35AB 583.33B 709.36A 610.90AB 30.23 0.0434
 BWG, g 258.41A 242.10A 329.94A 231.68A 28.10 0.0898
 FI, g/bird/day 78.70A 88.16A 86.77A 82.44A 6.08 0.6864
 FCR 1.90A 2.02A 1.52A 3.34A 0.84 0.4629
Days 21–28
 Day 28 BW, g 1292.32A 1121.92B 1352.72A 1394.23A 38.37 0.0008
 BWG, g 670.97AB 531.92B 643.36AB 783.33A 38.68 0.0032
 FI, g/bird/day 296.79A 292.01A 357.28A 351.49A 28.96 0.2824
 FCR 3.07A 4.14A 4.10A 3.13A 0.52 0.3192
Days 28–35
 Day 35 BW, g 1935.92A 1847.17A 2025.32A 2018.63A 47.01 0.0648
 BWG, g 643.61A 725.25A 672.61A 624.40A 43.82 0.4593
 FI, g/bird/day 150.40A 201.94A 155.85A 187.38A 27.80 0.5428
 FCR 1.74A 2.01A 1.67A 2.06A 0.32 0.7782
Days 35–42
 Day 42 BW, g 2799.75A 2749.44A 2874.86A 2835.99A 56.11 0.4954
 BWG, g 863.83A 902.28A 849.54A 817.36A 47.24 0.6835
 FI, g/bird/day 183.59A 176.74A 188.32A 179.27A 6.29 0.6151
 FCR 1.50A 1.39A 1.56A 1.54A 0.05 0.1237
DOH‑day 15
 BWG, g 325.52AB 303.86B 341.58A 341.82A 7.84 0.0079
 FI, g/bird/day 38.62A 41.17A 43.10A 43.50A 2.68 0.5680
 FCR 1.84B 2.44A 1.93AB 1.93AB 0.15 0.0358
Days 15–35
 BWG, g 1572.99A 1497.69A 1645.91A 1639.41A 47.24 0.1589
 FI, g/bird/day 164.29A 183.29A 189.41A 192.51A 11.64 0.3432
 FCR 2.11A 2.08A 2.32A 2.76A 0.35 0.5153
DOH‑day 42
 BWG, g 2762.33A 2712.07A 2837.03A 2798.59A 56.22 0.4999
 FI, g/bird/day 107.01A 113.48A 122.96A 120.47A 4.40 0.0775
 FCR 1.63A 1.76A 1.82A 1.81A 0.06 0.1383
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birds (P =  0.0434). However, the average body weights 
of CON and VPC birds did not differ significantly from 
each other or the other treatments on day 21. Average 
BW on day 28 showed a significant effect of treatment, 
with VNC birds weighing less than all other treatments 
(P = 0.0008).
Body weight gain (BWG)
A significant effect of treatment was seen from DOH-
day 15 regarding BWG, with probiotic-treated birds 
(NPC and VPC) gaining more weight than VNC birds 
(P = 0.0079). Within the starter phase, from days 7–15, 
VPC birds gained more weight than VNC birds only 
(P  =  0.0289). The same trend was observed from days 
21–28, where VPC birds had significantly higher BWG 
than VNC birds, with CON and NPC birds demonstrat-
ing comparable weight gains (P = 0.0032).
Feed intake (FI)
A significant effect of treatment was seen from days 7–15 
regarding FI, with VNC birds consuming more feed per 
day than CON birds (P = 0.0425).
Feed conversion ratio (FCR)
For the period prior to challenge (DOH-day 15), VNC 
birds had significantly higher FCR than CON birds 
(P = 0.0358). From days 7–15, VNC birds demonstrated 
higher FCR than all other treatments (P = 0.0074).
Discussion
In this study, the combined protective effects of probi-
otics and coccidiosis vaccine in the event of an Eimeria 
challenge were evaluated. Birds in the combined vaccine/
probiotic treatment group had less severe duodenal lesion 
scores than all other treatments. Further, CON birds had 
lesions of greater severity than VNC birds in the duode-
num, as well as lesion scores significantly greater than all 
other treatments in the jejunum. These findings suggest 
that probiotic supplementation, vaccine administration, 
and a combination of both help prevent damage to the 
intestine from coccidia. Similarly, Lee et al. [22] reported 
that birds given a Bacillus-based direct-fed microbial 
had significantly lower lesion scores in the gut than birds 
given the non-supplemented diet following an E. maxima 
challenge. Studies investigating necrotic enteritis (NE) in 
broilers found birds given two different blends of direct-
fed microbials had significantly reduced intestinal lesions 
due to NE than birds in the positive control [23]. Addi-
tionally, birds that received just a coccidiosis vaccine had 
less severe lesions in the upper and middle intestinal seg-
ments following challenge with three Eimeria species 
when compared to non-vaccinated birds that were fed 
therapeutic levels of an ionophore anticoccidial [16].
A second study found that birds given one of three dif-
ferent coccidiosis vaccine doses had less severe lesion 
scores than the positive non-vaccinated control [16]. Less 
severe lesion scores are indicative of less damage to the 
intestinal epithelium, leading to infected birds having a 
greater chance of recovery from disease. Numerous stud-
ies have found that probiotic supplementation leads to 
significant reductions in numbers of other intracellular 
pathogens [24, 25], which could prove to be exception-
ally beneficial to the bird, as some microorganisms such 
as Clostridium and Salmonella may exacerbate Eimeria 
infections and vice versa [26]. Ultimately, the reduction 
in the presence of intracellular pathogens is indicative 
of a healthier intestine, with minimal damage done to 
the epithelium. An intact intestinal epithelium serves as 
the vital barrier preventing entry of potential pathogens 
and results in proper nutrient absorption and utilization, 
leading to optimal health and performance of the bird.
The presence of oocysts in the litter and excreta after 
vaccination is crucial in vaccinated flocks, as it indicates 
proper vaccine uptake. Vaccine efficacy is dependent 
upon the infectivity and fecundity of oocysts, since pro-
tective immunity is induced after two to three consecu-
tive infections [14, 27, 28]. The re-infections are initiated 
by recycling of initially low doses of oocysts which result 
in gradual buildup and maintenance of immunity, and 
such recycling can be impacted by a number of factors 
including litter moisture content [29, 30]. The percent 
moisture in VNC pens was significantly lower on day 7, 
day 14, and day 42. Numerous studies have found that 
oocysts sporulate better in drier litter conditions, sug-
gesting maximum sporulation rate and litter moisture are 
indirectly correlated [14, 26, 31]. As the infective state of 
the Eimeria life cycle is the sporulated oocyst, birds on 
litter with lower percent moisture could be introduced to 
a greater number of infective oocysts, leading to a heavier 
infection. Bloody diarrhea is commonly associated with 
E. tenella, which was present in the challenge inoculum. 
However, as no significant differences were noted, the 
dose of E. tenella present in the fresh vaccine may not 
have been sufficient to cause extensive damage to the site 
of infection, as confirmed by the absence of lesions in the 
ceca.
Vaccine-plus-probiotic gel application birds demon-
strated significantly greater weight gains from DOH to 
day 15 when compared to VNC birds, suggesting the addi-
tion of probiotics helped the birds counter the reduction 
in growth associated with administration of coccidiosis 
live vaccines. However, the lack of a significant difference 
among treatments regarding BW at the end of the trial 
indicates VNC birds experienced compensatory growth 
following the initial setback from vaccination. These 
results coincide with the findings of Li et al. [16], in which 
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a “reaction” caused by some doses of vaccine resulted 
in delayed growth and coccidial lesions during the two 
weeks following vaccination. However, the vaccinated 
birds exhibited a compensatory weight gain that brought 
them to weights almost equal to the unchallenged control 
by 5–6 weeks of age [16]. The effect of Eimeria challenge 
on BW and BWG is not surprising, as coccidial infections 
are known to cause damage to the intestinal mucosa and 
enterocytes during the progression of their lifecycle. Sig-
nificant damage causes nutrient malabsorption and sub-
sequent reduced performance. Furthermore, parasitic 
infections result in nutrient resource allocation shifting 
from growth to immune response, which can also lead to 
noticeable differences in growth [15, 29]. Numerous stud-
ies investigating probiotics as dietary additives in poul-
try have resulted in varying effects of those probiotics on 
performance. Some reported that probiotic supplementa-
tion in the diet can improve BWG and FCR in chickens 
[8, 32–34], while others found no significant benefit to 
probiotic addition [35, 36]. These differences could be due 
to a variety of factors that can alter the efficacy of a pro-
biotic such as strain(s) of bacteria utilized, composition 
and viability of the probiotic bacteria, and the preparation 
methods. Further, other factors may include probiotic 
dosage, method and/or frequency of application, overall 
diet, condition and age of the birds, presence or absence 
of disease challenges, potential drug interactions, as well 
as environmental stress factors such as temperature and 
stocking density [5, 37].
Live vaccines offer a route of protection that circum-
vents the issue of developing drug-resistant coccidia [14, 
26]. As vaccination induces protective immunity due 
to exposure of the immune system to Eimeria antigens, 
the birds may respond with a strong immune response 
more quickly to a field strain Eimeria infection [13, 28]. 
In conclusion, the administration of probiotics (PoultryS-
tar) and coccidiosis vaccine (Immucox I) resulted in an 
enhanced protective effect against Eimeria acervulina 
and E. maxima challenge. The results of this study sug-
gest that the combination of probiotics and coccidiosis 
vaccine can, when compared to untreated controls, result 
in better performance and intestinal response. Early 
establishment of beneficial microbiota by probiotics can 
inhibit pathogens thus potentiating a protective effect 
and enhancing host resistance to infection while reduc-
ing the need for prophylactic drug usage [5, 19, 38]. As 
PoultryStar is a product that contains multiple probi-
otic species of bacteria, there is a greater potential that 
such probiotics can be active in a wider range of condi-
tions, similar to other multi-strain probiotics, resulting 
in greater efficacy [3, 39]. Probiotics may enhance host 
defenses and improve vaccine response as a result of the 
influence of beneficial bacteria on host immunity and 
intestinal integrity against enteric pathogens [13, 17]. 
Together, probiotics and coccidiosis vaccines can benefit 
performance and provide an augmented protective effect 
in the event of an Eimeria challenge.
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